Pathology of asbestosis - An update of the diagnostic criteria report of the asbestosis committee of the college of american pathologists and pulmonary pathology society

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 3, 2010, Pages 462-480

  Roggli, Victor L ^a   Gibbs, Allen R ^b   Attanoos, Richard ^b   Churg, Andrew ^c   Popper, Helmut ^d   Cagle, Philip ^e   Corrin, Bryan ^f   Franks, Teri J ^g   Galateau Salle, Francoise ^h,i   Galvin, Jeff ^g   Hasleton, Philip S ^j   Henderson, Douglas W ^k   Honma, Koichi ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b LLANDOUGH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e HOUSTON METHODIST HOSPITAL   (United States)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

^g ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^h CAEN UNIVERSITY HOSPITAL   (France)

ⁱ WYTHENSHAWE HOSPITAL   (United Kingdom)

^j FLINDERS MEDICAL CENTRE   (Australia)

^k DOKKYO MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIBOLE; CHRYSOTILE; MINERAL FIBER;

ARTICLE; ASBESTOSIS; BRONCHIOLITIS; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; HUMAN; LUNG FIBROSIS; MEDICAL SOCIETY; PRACTICE GUIDELINE; THORAX RADIOGRAPHY; UNITED STATES;

ASBESTOS, AMPHIBOLE; ASBESTOS, SERPENTINE; ASBESTOSIS; BRONCHIOLITIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MINERAL FIBERS; PRACTICE GUIDELINES AS TOPIC; PULMONARY FIBROSIS; RADIOGRAPHY, THORACIC; SOCIETIES, MEDICAL; UNITED STATES;

EID: 77749306527     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (117)

1. Craighead JE, Abraham JL, Churg A, et al; for Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. The pathology of asbestos associated disease of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Arch Pathol Lab Med. 1982;106(11):544-596.
2. Ministry of Industry. Report of the Chief Inspector of Factories for England and Wales for 1898, London, England: Her Majesty's Stationery Office; 1898: 171.
3. Departmental Committee on Compensation for Industrial Disease. Report and Minutes of Evidence. London, England: Her Majesty's Stationery Office; 1907.
4. Pancoast HK, Miller TG, Landris HRM. A roentgenologic study of the effects of dust inhalation of the lung. Trans Assoc Am Physicians. 1917;32:97-108.
5. Cooke WE. Pulmonary asbestosis. BMJ. 1927;2(3491):1024-1025.
6. Merewether ERA, Price CW. Report on the Effects of Asbestos Dust on the Lungs and Dust Suppression in the Asbestos Industry. London, England: Her Majesty's Stationery Office; 1930.
7. Wood WB, Gloyne SR. Pulmonary asbestosis: a review of 100 cases. Lancet. 1934;224(5808):1383-1385.
8. Gloyne SR. Two cases of squamous carcinoma of the lung occurring in asbestosis. Tubercle. 1935;17:5-10.
9. Lynch KM, Smith WA. Pulmonary asbestosis III: carcinoma of the lung in asbestos-silicosis. Am J Cancer. 1935;24:56-64.
10. Merewether ERA. Annual Report of the Chief Medical Inspector of Factories for 1947. London, England: Her Majesty's Stationery Office; 1949.
11. Gloyne SR. Pneumoconiosis: a histological survey of autopsy material in 1205 cases. Lancet. 1951;1(6659):810-814.
12. Breslow L. Industrial aspects of bronchogenic neoplasms. Dis Chest. 1955; 28(4):421-430.
13. Doll R. Mortality from cancer of the lung in asbestos workers. Br J Ind Med. 1955;12(2):81.
14. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in North Western Cape Province. Br J Ind Med. 1960;17:260.
15. Stanton MF, Wrench C. Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst. 1972;48(3):797-821.
16. Stanton MF, Layard M, Tegeris A, Miller E, May M, Kent E. Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst. 1977;58(3): 587-603.
17. Stanton MF, Layard M, Tegeris A, et al. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst. 1981;67(5):965-975.
18. Pott F. Some aspects on the dosimetry of the carcinogenic potency of asbestos and other fibrous dusts [in German]. Staub-Reinhalt Luft. 1978;38:486-490.
19. Pott F. Problems in defining carcinogenic fibers. Ann Occup Hyg. 1987; 31(4B):799-802.
20. Pott F, Huth F, Friedrichs KH. Tumorigenic effects of fibrous dusts in experimental animals. Environ Health Perspect. 1974;9:313-315.
21. Baris YL, Artvinli M, Sahin AA. Environmental mesothelioma in Turkey. Ann N Y Acad Sci. 1979;330:423-432.
22. Wagner JC, Skidmore JW, Hill RJ, Griffiths DM. Erionite exposure and mesotheliomas in rats. Br J Cancer. 1985;51(5):727-730.
23. Wagner, JC, ed. Biological Effects of Mineral Fibers. Lyon, France: IARC Press; 1979.
24. [ILO] International Labour Organization. International Classification of Radiographs of the Pneumoconiosis. Geneva, Switzerland: ILO; 1980. Occupational Safety and Health Series; no.22 (rev ed).
25. Churg A, Wright JL. Small airways disease and mineral dust exposure. Pathol Annu. 1983;18(pt 2):233-251.
26. Auerbach O, Garfinkel L, Hammond EC. Relation of smoking and age to findings in lung parenchyma: a microscopic study. Chest. 1974;65(1):29-35.
27. Roggli VL, Pratt PC. Numbers of asbestos bodies on iron-stained tissue sections in relation to asbestos body counts in lung tissue digests. Hum Pathol. 1983;14(4):355-361.
28. Roggli VL, Pratt PC, Brody AR. Analysis of tissue mineral fiber content. In: Roggli VL, Greenberg SD, Pratt PC, eds. Pathology of Asbestos-Associated Diseases. Boston, MA: Little, Brown & Co Inc; 1992:299-345.
29. Vollmer RT, Roggli VL. Asbestos body concentrations in human lung: predictions from asbestos body counts in tissue sections using a mathematical model. Hum Pathol. 1985;16(7):713-718.
30. Tossavainen A, reporter. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution [Record of discussion]. Scand JWork Environ Health. 1997;23(4):311-316.
31. Dupres JS, Mustard JF, Uffen RJ. Report of the Royal Commission on Matters of Health and Safety Arising From the Use of Asbestos in Ontario. Toronto, Canada: Queen's Printer for Ontario; 1984.
32. Churg A, Wiggs B, Depaoli L, Kampe B, Stevens B. Lung asbestos content in chrysotile workers with mesothelioma. Am Rev Respir Dis. 1984;130(6):1042-1045.
33. Hodgson JT, Darnton A. The quantitative risk of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000;44(8):565-601.
34. Shilkin K, de Klerk N, Henderson D, et al. The diagnosis and attribution of asbestos related diseases in an Australian context: Adelaide Workshop on Asbestos Related Diseases. J Occup Health Saf Aust N Z. 2002;18:443-452.
35. Eastern Research Group, Inc. Prepared for: Agency for Toxic Substances and Disease Registry (ATSDR). Report on the Expert Panel on Health Effects of Asbestos and Synthetic Vitreous Fibers: The Influence of Fiber Length [Record of discussion]. New York, NY, October 29-30, 2002. Atlanta, GA: ATSDR; 2003.
36. Hume LA, Rimstidt JD. The biodurability of chrysotile. Am Mineral. 1992; 77(9-10):1125-1128.
37. Bernstein DM, Rogers R, Smith P. The biopersistence of Canadian chrysotile asbestos following inhalation. Inhal Toxicol. 2003;15(13):1247-1274.
38. Churg A, Wright JL. Persistence of natural mineral fibers in human lungs: an overview. Environ Health Perspect. 1994;102(suppl 5):229-233.
39. Hesterberg TW, Chase G, Axten C, et al. Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol Appl Pharmacol. 1998;151(2):262-275.
40. Bandli BR, Gunter ME. A review of scientific literature examining the mining history, geology, mineralogy, and amphibole asbestos health effects of the Rainy Creek igneous complex, Libby, Montana, USA. Inhal Toxicol. 2006;18(12): 949-962.
41. Berman DW, Crump KS. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 2008;38(suppl 1):1-47.
42. Berman DW, Crump KS. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol. 2008;38(suppl 1):49-73.
43. McDonald JC, Harris J, Armstrong B. Mortality in a cohort of vermiculite miners exposed to fibrous amphibole in Libby, Montana. Occup Environ Med. 2004;61(4):363-366.
44. Hesterberg TW, Hart GA. Synthetic vitreous fibers: a review of toxicology research and its impact on hazard classification. Crit Rev Toxicol. 2001;31(1):1-53.
45. Hesterberg TW, Hart GA, Chevalier J, Thevenaz P, et al. The importance of fiber biopersistence and lung dose in determining the chronic inhalation effects of X607, RCF1, and chrysotile asbestos in rats. Toxicol Appl Pharmacol. 1998; 153(1):68-82.
46. Bernstein DM, Hoskins JA. The health effects of chrysotile: current perspective based upon recent data. Regul Toxicol Pharmacol. 2006;45(3):252-264.
47. Churg A, Wright JL, Vedal S. Fiber burden and patterns of disease in chrysotile miners and millers. Am Rev Respir Dis. 1993;148(1):25-31.
48. Churg A, Vedal S. Fiber burden and patterns of asbestos-related disease in workers with heavy mixed amosite and chrysotile exposure. Am J Respir Crit Care Med. 1994;150(3):663-669.
49. Browne K. Asbestos-related disorders. In: Parkes WR, ed. Occupational Lung Disorders, 3rd ed. Oxford, England: Butterworth-Heinemann; 1994:411-504.
50. Baris YI, Grandjean P. Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite. J Natl Cancer Inst. 2006;98(6): 414-417.
51. Emri S, Demir A, Dogan M, et al. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett. 2002;127(1):251-257.
52. Wagner JC, Moncrieff CB, Coles R, Griffiths DM, Munday DE. Correlation between fibre content of the lungs and disease in naval dockyard workers. Br J Ind Med. 1986;43(6):391-395.
53. Roggli VL. Asbestos bodies and nonasbestos ferruginous bodies. In: Roggli VL, Oury TD, Sporn TA, eds. Pathology of Asbestos-Associated Diseases. 2nd ed. New York, NY: Springer; 2004:34-70.
54. Gibbs AR, Pooley FD. Analysis and interpretation of inorganic mineral particles in "lung" tissues. Thorax. 1996;51(3):327-334.
55. De Vuyst P, Karjalainen A, Dumortier P, et al; European Respiratory Society. Guidelines for mineral fibre analyses in biological samples: report of the ERS Working Group. Eur Respir J. 1998;11(16):1416-1426.
56. Roggli VL, Pratt PC, Brody AR. Asbestos content in lung tissue in asbestos associated disease: a study of 110 cases. Br J Ind Med. 1986;153:444-449.
57. Gibbs AR, Gardner MJ, Pooley FD, et al. Fibre levels and disease in workers from a factory using predominantly amosite. Environ Health Perspect. 1994;102(suppl 5):261-263.
58. Albin M, Johansson L, Pooley FD, et al. Mineral fibres, fibrosis, and asbestos bodies in lung tissue from deceased asbestos cement workers. Br J Ind Med. 1990;47(11):767-774.
59. Ashcroft T, Heppleston AG. The optical and electron microscopic determination of pulmonary asbestos fibre concentration and its relation to the human pathological reaction. J Clin Pathol. 1973;26(3):224-243.
60. Pooley FD, Ransome DL. Comparison of the results of asbestos fibre counts in lung tissue obtained by analytical electron microscopy and light microscopy. J Clin Pathol. 1986;39(3):313-317.
61. Churg A. Fibre counting and analysis in the diagnosis of asbestos fibres from lung tissue. Human Pathol. 1982;13(4):381-392.
62. Wagner JC, Newhouse ML, Corrin B, Rossiter CE, Griffiths DM. Correlation between fibre content of the lung and disease in east London asbestos factory workers. Br J Ind Med. 1988;45(5):305-308.
63. Beeston BEP. The formation of a useful diffraction pattern from a specimen in the electron microscope, In: Glauert M, ed. Electron Diffraction and Optical Diffraction Techniques. Amsterdam, Netherlands: North Holland Publishing Co; 1972:252-285.
64. Karjalainen A. ed. Final Report: Measurement and Testing Programme Project MAT1-CT94-0072-Reference Materials for the Analysis of Asbestos Fibres in Lung Tissue. Helsinki, Finland: Finnish Institute of Occupational Health; 1996.
65. Roggli VL. Scanning electron microscopic analysis of mineral fiber content of lung tissue in the evaluation of diffuse pulmonary fibrosis. Scanning Microsc. 1991;5(1):71-83.
66. Becklake MR. Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice. Am Rev Respir Dis. 1976; 114(1):187-227.
67. De Vuyst P, Gevenois PA. Asbestosis. In: Hendrick DJ, Burge PS, Beckett WS, Churg A, eds. Occupational Disorders of the Lung: Recognition, Management, and Prevention. London, England: Saunders; 2002:143-162.
68. Ross RM. The clinical diagnosis of asbestosis in this century requires more than a chest radiograph. Chest. 2003;124(3):1120-1128.
69. O'Reilly KM, McLaughlin AM, Beckett WS, Sime PJ. Asbestos-related lung disease. Am Fam Physician. 2007;75(5):683-688.
70. Wang X, Yano E, Wang Z, et al. Adverse effects of asbestos exposure and smoking on lung function. Am J Ind Med. 2006;49(5):337-342.
71. Wang XR, Yano E, Wang M, et al. Pulmonary function in long-term asbestos workers in China. J Occup Environ Med. 2001;43(7):623-629.
72. Oksa P, Klockars M, Karjalainen A, et al. Progression of asbestosis predicts lung cancer. Chest. 1998;113(6):1517-1521.
73. Browne K. A threshold for asbestos-related lung cancer. Br J Ind Med. 1986;43(8):556-558.
74. Churg A. Nonneoplastic disease caused by asbestos. In: Churg A, Green FHY, eds. Pathology of Occupational Lung Disease. 2nd ed. Baltimore, MD: Williams & Wilkins; 1998:277-338.
75. Gibbs G, Pigg BJ, Nicholson WJ, et al. Environmental Health Criteria 203: Chrysotile Asbestos. Geneva, Switzerland: United Nations Environment Programme, the International Labour Organization, and World Health Organization; 1998.
76. Green FH, Harley R, Vallyathan V, et al. Exposure and mineralogical correlates of pulmonary fibrosis in chrysotile asbestos workers. Occup Environ Med. 1997;54(8):549-559.
77. Fischer M, Gunther S, Muller KM. Fibre-years, pulmonary asbestos burden and asbestosis. Int J Hyg Environ Health. 2002;205(3):245-248.
78. Burdorf A, Swuste P. An expert system for the evaluation of historical asbestos exposure as diagnostic criterion in asbestos-related diseases. Ann Occup Hyg. 1999;43(1):57-66.
79. Dement JM, Harris RL, Jr., Symons MJ, Shy CM. Exposures and mortality among chrysotile asbestos workers, part II: mortality. Am J Ind Med. 1983;4(3): 421-433.
80. Sluis-Cremer GK. Asbestos disease at low exposures after long residence times. Ann N Y Acad Sci. 1991;643:182-193.
81. Browne K. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure [letter]. Ann Occup Hyg. 2001;45(4):327-329; discussion: 36-38.
82. Rödelsperger K, Schneider J, Woitowitz H-J. Umwelt- und Innenraumgefährdung durch Asbestfaserstaub ausserhalb des Arbeitsplatzes. Gefahrstoffe- Reine Luft. 1996;56:117-126. (Pubitemid 26130604)
83. Henderson DW, Rö delsperger K, Woitowitz H-J, Leigh J. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. Pathology. 2004; 36(6):517-550.
84. Akira M, Yamamoto S, Inoue Y, Sakatani M. High resolution CT of asbestosis and idiopathic pulmonary fibrosis. Am J Roentgenol. 2003;181(1):163-169.
85. Copley SJ, Wells AU, Slvakumaran P, et al. Asbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT features. Radiology. 2003; 229(3):731-736.
86. International Labour Organization. International Classification of Radiographs of the Pneumoconiosis. Geneva, Switzerland: ILO; 2002. Occupational Safety and Health Series; no.22 (rev 2000).
87. Epler GR, McLoud TC, Gaensler EA, Mikus JP, Carrington CB: Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med. 1978;298(17):934-939.
88. Kipen HM, Lilis R, Suzuki Y, Valciukas JA, Selikoff IJ. Pulmonary fibrosis in asbestos insulation workers with lung cancer: a radiological and histopathological evaluation. Br J Ind Med. 1987;44(2):96-100.
89. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004; 170(6):691-715.
90. Staples CA, Gamsu G, Ray CS, Webb NR. High resolution computed tomography and lung function in asbestos-exposed workers with normal chest radiographs. Am Rev Respir Dis. 1989;139(6):1502-1508.
91. Gevenois PA, De Vuyst P, Dedeire S, Cosaert J, Vande Weyer R, Struyven J. Conventional and high-resolution CT in asymptomatic asbestos-exposed workers. Acta Radiol. 1994;35(3):226-229.
92. Akira M, Yamamoto S, Yokoyama K, et al. High-resolution CT-pathologic correlation. Radiology. 1990;176(2):389-394.
93. Akira M, Yokoyama K, Yamamoto S, et al. Early asbestosis: evaluation with high-resolution CT. Radiology. 1991;178(2):409-416.
94. Gevenois PA, de Maertelaer V, Madani A, Winant C, Sergent G, De Vuyst P. Asbestosis, pleural plaques, and diffuse pleural thickening: three distinct benign responses to asbestos exposure. Eur Respir J. 1998;11(5):1021-1027.
95. Gamsu G, Salmon CJ, Warnock ML, Blanc PD. CT quantification of interstitial fibrosis in patients with asbestosis: a comparison of two methods. Am J Roentgenol. 1995;164(1):63-68.
96. Hartley PG, Galvin JR, Hunninghake GW, et al. High-resolution CTderived measures of lung density are valid indexes of interstitial lung disease. J Appl Physiol. 1994;76(1):271-277.
97. Schwartz DA, Galvin JR, Yagla SJ, Speakman SB, Merchant JA, Hunninghake GW. Restrictive lung function and asbestos-induced pleural fibrosis: a quantitative approach. J Clin Invest. 1993;91(6):2685-2692.
98. Copley SJ, Lee YCG, Hansell DM, et al. Asbestos-induced and smokingrelated disease: apportioning pulmonary function deficit by using thin-section CT. Radiology. 2007;242(1):258-266.
99. Roggli VL, Cagle PT. Emphysema and chronic bronchitis. In: Tomashefski TF, Cagle PT, Farver CF, Fraire AE, eds, Dail and Hammar's Pulmonary Pathology. 3rd ed. New York, New York: Springer-Verlag; 2008:866-885.
100. Hillerdal G. Asbestos exposure and upper lobe involvement. Am J Roentgenol. 1982;139(6):1163-1166.
101. Sporn TA, Roggli VL. Asbestosis. In: Roggli VL, Oury TD, Sporn TA, eds. Pathology of Asbestos-Associated Diseases. 2nd ed. New York, New York: Springer; 2004:71-103.
102. Churg A, Wright JL. Small airway lesions in patients exposed to nonasbestos mineral dusts. Hum Pathol. 1983;14(8):688-693.
103. Holden J, Churg A. Asbestos bodies and the diagnosis of asbestosis in chrysotile workers. Environ Res. 1986;39(1):232-236.
104. Roggli VL, Benning TL. Asbestos bodies in pulmonary hilar lymph nodes. Mod Pathol. 1990;3(4):513-517.
105. Craighead JE, Kleinerman J, Abraham JL, et al; for Silicosis and Silicate Disease Committee. Diseases associated with exposure to silica and nonfibrous silicate minerals. Arch Pathol Lab Med. 1988;112(7):673-720.
106. Kuhn C, Kuo T-T. Cytoplasmic hyaline in asbestosis: a reaction of injured alveolar epithelium. Arch Pathol. 1973;95(3):190-194.
107. Joines RA, Roggli VL. Dendriform pulmonary ossification: report of two cases with unique findings. Am J Clin Pathol. 1989;91(4):398-402.
108. Koss MN, Johnson FB, Hochholzer L. Pulmonary blue bodies. Hum Pathol. 1981;12(3):258-266.
109. Roggli VL. Pathology of human asbestosis: a critical review. In: Fenoglio-Preiser CM, ed. Advances in Pathology. Vol.2. Chicago, IL: Yearbook Publishers; 1989:31-60.
110. Hammar SP, Dodson RF: Asbestos. In: Tomashefski TF, Cagle PT, Farver CF, Fraire AE, eds. Dail and Hammar's Pulmonary Pathology. 3rd ed. New York, New York: Springer-Verlag; 2008:950-1031.
111. Sporn TA, Butnor KJ, Roggli VL. Cytopathology of asbestos-associated diseases. In: Roggli VL, Oury TD, Sporn TA, eds. Pathology of Asbestos- Associated Diseases. 2nd ed. New York, NY: Springer; 2004:231-255.
112. Popper HH, Pongratz M. Aussage-und Einsatzmöglichkeiten der bronchioloalveolären lavage kombiniert mit transbronchialer lungenbiopsie [Value and indications for bronchoalveolar lavage combined with transbronchial lung biopsy] In German. Wien Klin Wochenschr. 1987;99(24):848-855.
113. Honma K, Abraham JL, Chiyotani K, et al. Proposed criteria for mixed dust pneumoconiosis: definition, descriptions, and guidelines for pathologic diagnosis and clinical correlation. Hum Pathol. 2004;35:1515-1523.
114. Corrin B, Price AB. Electron microscopic studies in desquamative interstitial pneumonia associated with asbestos. Thorax. 1972;27(3):324-331.
115. Travis WD, King TE, Bateman ED, et al; for American Thoracic Society/ European Respiratory Society International. Multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165(2):277-304. Erratum in: Am J Respir Crit Care Med, 2002; 166(3):426.
116. Roggli VL, Sharma A. Analysis of tissue mineral fiber content. In: Roggli VL, Oury TD, Sporn TA, eds. Pathology of Asbestos-Associated Diseases. 2nd ed. New York, NY: Springer; 2004:309-354.
117. Gaensler EA, Jederlinic PJ, Churg A: Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis. 1991;144(3, pt 1):689-696.